These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27628669)

  • 21. The anti-intellectual effects of intellectual property.
    Lipinski CA
    Curr Opin Chem Biol; 2006 Aug; 10(4):380-3. PubMed ID: 16829159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Academic-Pharma drug discovery alliances: seeking ways to eliminate the valley of death.
    Hammonds T
    Future Med Chem; 2015; 7(14):1891-9. PubMed ID: 26393391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translational research: the changing landscape of drug discovery.
    Fishburn CS
    Drug Discov Today; 2013 May; 18(9-10):487-94. PubMed ID: 23247258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developing new treatments in partnership for primary mitochondrial disease: What does industry need from academics, and what do academics need from industry?
    Thompson PW
    J Inherit Metab Dis; 2021 Mar; 44(2):301-311. PubMed ID: 33141457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioanalytical outsourcing strategy at Janssen Research and Development.
    Verhaeghe T
    Bioanalysis; 2014 May; 6(10):1321-7. PubMed ID: 24958116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From challenges to solutions. European Bioanalysis Forum 3rd Annual Open Symposium, Hesperia Towers, Barcelona, Spain, 1-3 December 2010.
    Abbott RW; Gordon B; van Amsterdam P; Lausecker B; Brudny-Kloeppel M; Smeraglia J; Romero F; Globig S; Golob M; Knutsson M; Herling C; Vieser E; Timmerman P
    Bioanalysis; 2011 Apr; 3(8):833-8. PubMed ID: 21510756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A high efficiency, high quality and low cost internal regulated bioanalytical laboratory to support drug development needs.
    Song Y; Dhodda R; Zhang J; Sydor J
    Bioanalysis; 2014 May; 6(10):1295-309. PubMed ID: 24958114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatology.
    Prendergast MM; Abramovits W; Boguniewicz M; Lebwohl M; Tokar M; Tong KB
    J Invest Dermatol; 2004 Sep; 123(3):452-4. PubMed ID: 15304081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Academia-industry alliance: Belfer Institute and sanofi-aventis collaborate to develop new cancer therapeutics.
    Dis Model Mech; 2010; 3(11-12):669. PubMed ID: 21030419
    [No Abstract]   [Full Text] [Related]  

  • 33. Request for global harmonization of the guidance for Bioanalytical Method Validation and sample analysis.
    Timmerman P; Lowes S; Fast DM; Garofolo F
    Bioanalysis; 2010 Apr; 2(4):683. PubMed ID: 21083261
    [No Abstract]   [Full Text] [Related]  

  • 34. Proteomics in pharmaceutical research and development.
    Cutler P; Voshol H
    Proteomics Clin Appl; 2015 Aug; 9(7-8):643-50. PubMed ID: 25763573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addressing the right targets in oncology: challenges and alternative approaches.
    Stock JK; Jones NP; Hammonds T; Roffey J; Dillon C
    J Biomol Screen; 2015 Mar; 20(3):305-17. PubMed ID: 25614505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of a protein profiling platform developed as an academic-pharmaceutical industry collaborative effort.
    Végvári A; Magnusson M; Wallman L; Ekström S; Bolmsjö G; Nilsson J; Miliotis T; Ostling J; Kjellström S; Ottervald J; Franzén B; Hultberg H; Marko-Varga G; Laurell T
    Electrophoresis; 2008 Jun; 29(12):2696-705. PubMed ID: 18512682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers: a valuable tool in clinical research and medical practice.
    Carini C
    IDrugs; 2007 Jun; 10(6):395-8. PubMed ID: 17642003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug discovery in academia.
    Shamas-Din A; Schimmer AD
    Exp Hematol; 2015 Aug; 43(8):713-7. PubMed ID: 25912018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical drug development.
    Brodniewicz T; Grynkiewicz G
    Acta Pol Pharm; 2010; 67(6):578-85. PubMed ID: 21229871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.